Found: 31
Select item for more details and to access through your institution.
Prevalence of human papillomavirus infection and RAS mutation in sporadic keratoacanthoma.
- Published in:
- International Journal of Dermatology, 2015, v. 54, n. 11, p. e453, doi. 10.1111/ijd.12669
- By:
- Publication type:
- Article
Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor--Positive Metastatic Breast Cancer.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1198, doi. 10.4143/crt.2022.1543
- By:
- Publication type:
- Article
Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma.
- Published in:
- Cancer Research & Treatment, 2018, v. 50, n. 4, p. 1238, doi. 10.4143/crt.2017.534
- By:
- Publication type:
- Article
Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.689587
- By:
- Publication type:
- Article
De novo versus recurrent metastatic breast cancer affects the extent of brain metastases.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 169, n. 2, p. 309, doi. 10.1007/s11060-024-04735-x
- By:
- Publication type:
- Article
Correction to: Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 183, n. 1, p. 107, doi. 10.1007/s10549-020-05750-y
- By:
- Publication type:
- Article
Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 179, n. 3, p. 687, doi. 10.1007/s10549-019-05505-4
- By:
- Publication type:
- Article
Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma.
- Published in:
- Oncology, 2019, v. 96, n. 2, p. 59, doi. 10.1159/000492597
- By:
- Publication type:
- Article
Assessment of Adrenal Function and Health-Related Quality of Life in Advanced Gastric Cancer Patients Who Received First-Line Chemotherapy.
- Published in:
- Oncology, 2016, v. 90, n. 5, p. 248, doi. 10.1159/000445010
- By:
- Publication type:
- Article
Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 9, p. 1036, doi. 10.1093/jnci/djad080
- By:
- Publication type:
- Article
Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy.
- Published in:
- Yonsei Medical Journal, 2024, v. 65, n. 3, p. 129, doi. 10.3349/ymj.2023.0229
- By:
- Publication type:
- Article
Comparison of Programmed Cell Death Ligand 1 Status between Core Needle Biopsy and Surgical Specimens of Triple-Negative Breast Cancer.
- Published in:
- Yonsei Medical Journal, 2023, v. 64, n. 8, p. 518, doi. 10.3349/ymj.2023.0090
- By:
- Publication type:
- Article
Real-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer.
- Published in:
- Yonsei Medical Journal, 2019, v. 60, n. 6, p. 525, doi. 10.3349/ymj.2019.60.6.525
- By:
- Publication type:
- Article
PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates.
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-022-01601-4
- By:
- Publication type:
- Article
Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 2, p. 1409, doi. 10.1002/cam4.5022
- By:
- Publication type:
- Article
Clinical features and KRAS mutation in colorectal cancer with bone metastasis.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-78253-x
- By:
- Publication type:
- Article
Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 11, p. 3222, doi. 10.1245/s10434-018-6624-1
- By:
- Publication type:
- Article
Tumor-Infiltrating Lymphocyte Level Consistently Correlates with Lower Stiffness Measured by Shear-Wave Elastography: Subtype-Specific Analysis of Its Implication in Breast Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1254, doi. 10.3390/cancers16071254
- By:
- Publication type:
- Article
Predictive Markers of Treatment Response to Neoadjuvant Systemic Therapy with Dual HER2-Blockade.
- Published in:
- Cancers, 2024, v. 16, n. 4, p. 842, doi. 10.3390/cancers16040842
- By:
- Publication type:
- Article
Elasticity Values as a Predictive Modality for Response to Neoadjuvant Chemotherapy in Breast Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 377, doi. 10.3390/cancers16020377
- By:
- Publication type:
- Article
YAP1 Expression in HR+HER2− Breast Cancer: 21-Gene Recurrence Score Analysis and Public Dataset Validation.
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 5034, doi. 10.3390/cancers15205034
- By:
- Publication type:
- Article
SP142 PD-L1 Assays in Multiple Samples from the Same Patients with Early or Advanced Triple-Negative Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133042
- By:
- Publication type:
- Article
Analyses of CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC from ASTRIS Korean Subset, Open-Label Real-World Study.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3681, doi. 10.3390/cancers13153681
- By:
- Publication type:
- Article
Association between Skeletal Muscle Loss and the Response to Neoadjuvant Chemotherapy for Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1806, doi. 10.3390/cancers13081806
- By:
- Publication type:
- Article
A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Association between TP53 mutation and high 21-gene recurrence score in estrogen receptor-positive/HER2-negative breast cancer.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00384-3
- By:
- Publication type:
- Article
Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery.
- Published in:
- 2017
- By:
- Publication type:
- journal article